De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Wattanapat Hospital Trang Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Somchai Chansawang

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	geen gegevens

Recente managementupdates

Recent updates

CEO

Somchai Chansawang (68 yo)

no data

Tenure

Dr. Somchai Chansawang, M.D. serves as Chief of Executive Office, Acting Hospital Director and Director of Wattanapat Hospital Trang Public Company Limited. Dr. Chansawang served as Hospital Director of Ba...

Wattanapat Hospital Trang Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Wattanapat Hospital Trang Public Company Limited, Annual General Meeting, Apr 24, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Second quarter 2024 earnings released: EPS: ฿0.05 (vs ฿0.004 loss in 2Q 2023)

New major risk - Share price stability

First quarter 2024 earnings released: EPS: ฿0.17 (vs ฿0.032 in 1Q 2023)

Investor sentiment improves as stock rises 17%

Wattanapat Hospital Trang Public Company Limited Approves Dividend for the Year 2023, Payable on 21 May 2024

Upcoming dividend of ฿0.10 per share

Dividend of ฿0.10 announced

Wattanapat Hospital Trang Public Company Limited Proposes Dividend for the Year 2023, Payable on 21 May 2024

Full year 2023 earnings released: EPS: ฿0.15 (vs ฿0.19 in FY 2022)

Wattanapat Hospital Trang Public Company Limited, Annual General Meeting, Apr 24, 2024

Wattanapat Hospital Trang Public Company Limited has completed a Follow-on Equity Offering in the amount of THB 300 million.

Wattanapat Hospital Trang Public Company Limited has completed a Follow-on Equity Offering in the amount of THB 300 million.

Third quarter 2023 earnings released: EPS: ฿0.06 (vs ฿0.08 in 3Q 2022)

Wattanapat Hospital Trang Public Company Limited announced that it expects to receive THB 345 million in funding

Investor sentiment improves as stock rises 28%

New minor risk - Share price stability

New major risk - Dividend sustainability

Second quarter 2023 earnings released: ฿0.01 loss per share (vs ฿0.034 profit in 2Q 2022)

Investor sentiment improves as stock rises 16%

First quarter 2023 earnings released: EPS: ฿0.03 (vs ฿0.093 in 1Q 2022)

Upcoming dividend of ฿0.11 per share at 2.8% yield

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: ฿0.08 (vs ฿0.12 in 3Q 2021)

Less than half of directors are independent

Second quarter 2022 earnings released: EPS: ฿0.034 (vs ฿0.029 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: ฿0.094 (vs ฿0.022 loss in 1Q 2021)

Less than half of directors are independent

Investor sentiment improved over the past week

Upcoming dividend of ฿0.10 per share

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Wattanapat Hospital Trang Public Company Limited Approves to Propose Dividend Payment, Payable on 25 May 2022

Third quarter 2021 earnings released: EPS ฿0.12 (vs ฿0.004 loss in 3Q 2020)

Second quarter 2021 earnings released: ฿0.029 loss per share (vs ฿0.038 loss in 2Q 2020)

First quarter 2021 earnings released: ฿0.022 loss per share (vs ฿0.003 profit in 1Q 2020)

CEO

Tenure